-
Patients who have undergone bariatric surgery should take steps to be sure they are absorbing their medications and nutrients, according to University of Kentucky researchers writing in the Oct. 1, 2006, American Journal of Health-System Pharmacy.
-
Pharmacist-managed diabetes care clinics achieve high screening rates and attain treatment goals more often than national averages, according to two separate studies published in the American Journal of Health-System Pharmacy.
-
The frequency, severity, and preventability of adverse drug events (ADEs) in intensive care units (ICUs) are not associated with a drug's cost or frequency of use, according to researchers writing in the American Journal of Health System Pharmacy.
-
Oxymorphone hydrochloride (Opana® and Opana ER®) is a semi-synthetic opioid analgesic tablet for oral administration. It is a morphine-like agonist and a CII drug with an abuse liability similar to other opioids. Oxymorphone is available as 5 mg and 10 mg tablets for oral administration.
-
Clinicians who manage ventilator-associated pneumonia (VAP) patients should promote appropriate use of antibiotics to optimize patients' outcomes and prevent antibiotic resistance.
-
-
-
-
Seniors finally had the opportunity to enroll in a Medicare Part D plan beginning Nov. 15. More than half of those eligible, however, still are confused about the governments new prescription drug plan benefit, according to a Kaiser Health Poll Report conducted in August.
-
Much has been written about drugs and their adverse effects (AEs). But two pharmacists saw the need for a central source of information for an important subset of adverse effects: drug-induced diseases.
